Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1]. |
Molecular Weight | N/A |
CAS No. | 2244739-29-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cudarolimab 2244739-29-3 inhibitor inhibit